Signal Management Governance

Introduction

Signal management is often described in terms of technical activities such as signal detection, validation and assessment. However, signal management is also a governance process. Decisions regarding emerging safety concerns may influence product information, risk minimisation activities, regulatory communications and benefit-risk evaluations. Consequently, organisations require mechanisms to ensure that important signal-related decisions are made consistently, reviewed appropriately and documented adequately.

Governance provides the framework through which these activities are coordinated. It establishes responsibilities, defines decision-making authority, determines escalation requirements and ensures that significant safety concerns receive appropriate organisational visibility.

An effective governance framework does not replace scientific judgement. Rather, it provides a structured environment in which scientific judgement can be exercised consistently and transparently.

Why Governance Matters

Signal management activities frequently involve uncertainty. Decisions may need to be made using incomplete information, conflicting evidence or emerging observations that have not yet been fully characterised.

Without defined governance structures, organisations may encounter problems such as inconsistent decision-making, unclear accountability or delayed escalation of important safety concerns.

Governance contributes to:

• Accountability
• Consistency
• Transparency
• Oversight
• Regulatory compliance

The objective is not to create unnecessary bureaucracy. The objective is to ensure that safety-related decisions are visible, documented and appropriately reviewed.

Governance Within the Signal Management Lifecycle

Governance should support every stage of signal management.

A simplified lifecycle may be represented as:

Signal Detection
        ↓
Signal Validation
        ↓
Signal Assessment
        ↓
Decision Making
        ↓
Action or Closure

At each stage, governance arrangements help determine:

• Who performs the activity
• Who reviews the activity
• Who approves conclusions
• Who receives escalations

The level of governance required may vary depending upon the significance of the signal and the complexity of the product portfolio.

Defining Responsibilities

One of the primary objectives of governance is the allocation of responsibilities.

Signal management activities often involve multiple functions, including:

• Pharmacovigilance
• Safety physicians
• Epidemiologists
• Regulatory affairs
• Medical affairs
• Quality personnel

Roles should be defined clearly.

Ambiguity regarding responsibilities frequently contributes to delays, duplication of effort and inspection findings.

Organisations should be able to explain who is responsible for:

• Detection activities
• Validation decisions
• Signal assessments
• Escalation decisions
• Regulatory communications

These responsibilities should be reflected within procedures and governance documents.

Decision-Making Authority

Governance frameworks should define how decisions are made and who has authority to make them.

Examples of decisions may include:

• Whether a signal should be validated
• Whether additional assessment is required
• Whether escalation is necessary
• Whether regulatory action should be proposed

Not all decisions require the same level of review.

Routine signal closures may be managed at operational level, whereas signals with potential public health implications may require review by senior governance bodies.

Clearly defined decision-making authority helps ensure consistency and accountability.

Signal Review Committees

Many organisations utilise formal committees to support signal management activities.

Committee structures vary considerably between organisations but commonly include multidisciplinary participation.

Examples include:

• Signal Review Committees
• Safety Management Teams
• Product Safety Committees
• Benefit-Risk Review Committees

The purpose of such committees is not merely to review data.

They provide a forum for discussion, challenge and collective decision-making.

Committee structures are particularly valuable when evaluating signals with significant uncertainty or potential regulatory implications.

Escalation Pathways

Escalation is a critical governance function.

Most organisations review numerous observations during routine signal management activities. Only a subset of these observations require broader organisational visibility.

Governance frameworks should therefore define:

• Escalation criteria
• Escalation timelines
• Escalation recipients
• Documentation requirements

Escalation criteria may include:

• Potential public health impact
• Significant benefit-risk implications
• Emerging safety issues
• Potential regulatory action
• Significant media interest

The objective is to ensure that important concerns receive appropriate attention while avoiding unnecessary escalation of routine matters.

Emerging Safety Issues

Emerging safety issues frequently represent the highest level of signal-related escalation.

Governance arrangements should clearly describe:

• How potential ESIs are identified
• Who evaluates them
• Who is informed
• How decisions are documented

Because emerging safety issues may require accelerated assessment and communication, governance arrangements should support timely review without compromising scientific rigour.

Inspectors often examine ESI governance arrangements in detail.

Governance Documentation

Documentation provides evidence that governance activities have occurred.

Examples of governance records include:

• Committee agendas
• Meeting minutes
• Decision logs
• Escalation records
• Action trackers
• Assessment approvals

Documentation should allow reconstruction of:

• What information was reviewed
• Who reviewed it
• What conclusions were reached
• What actions were agreed

Governance decisions that cannot be reconstructed may be difficult to defend during inspections.

Integration With Benefit-Risk Evaluation

Signal management governance should not operate independently from broader pharmacovigilance governance.

Important signals may influence:

• PSUR conclusions
• Risk Management Plans
• Benefit-risk assessments
• Product information
• Regulatory submissions

Governance structures should therefore facilitate communication between signal management activities and other pharmacovigilance processes.

Inspectors frequently assess whether this integration exists in practice rather than only within procedures.

Integration With Risk Management Systems

Signal management and risk management systems are closely connected.

Signals may lead to:

• Identification of new risks
• Reclassification of potential risks
• Additional pharmacovigilance activities
• Additional risk minimisation measures

Governance frameworks should support communication between signal management functions and personnel responsible for risk management activities.

Failure to integrate these activities may result in inconsistent safety strategies.

Role of Senior Management

The degree of senior management involvement varies between organisations.

Routine signal activities generally do not require executive review.

However, significant safety concerns may require visibility at higher organisational levels, particularly when:

• Public health implications exist
• Major regulatory actions are anticipated
• Product information changes are proposed
• Significant business impacts may occur

Governance arrangements should define circumstances in which senior management involvement is required.

Role of the QPPV

The QPPV occupies an important position within signal management governance.

The QPPV is not normally responsible for conducting signal detection analyses or leading routine signal assessments. However, the QPPV should maintain visibility of significant signal-related activities and understand how governance arrangements support identification and management of safety concerns.

Inspectors commonly explore:

• Which signals are escalated to the QPPV
• How escalation occurs
• How emerging safety issues are communicated
• How benefit-risk implications are reviewed

The expectation is generally one of oversight rather than operational ownership.

A QPPV should be able to explain how the governance framework enables visibility of important safety concerns.

Outsourced Signal Management Activities

Signal management activities may be partially outsourced to vendors or service providers.

Examples include:

• Statistical signal detection
• Literature monitoring
• Epidemiological support
• Safety data analysis

Governance arrangements should ensure that outsourced activities remain visible and subject to appropriate oversight.

The Marketing Authorisation Holder retains responsibility for pharmacovigilance compliance irrespective of outsourcing arrangements.

Vendor governance should therefore include:

• Performance monitoring
• Escalation pathways
• Quality oversight
• Communication mechanisms

Governance During Inspections

Inspectors frequently assess governance arrangements because governance provides evidence that signal management activities operate in a controlled and consistent manner.

Inspection discussions may focus on:

• Committee structures
• Escalation records
• Decision-making processes
• QPPV visibility
• Governance documentation

Findings are often associated with weak governance implementation rather than deficiencies in technical signal management methodology.

The ability to explain how decisions are made and escalated is therefore particularly important.

Common Governance Weaknesses

Several governance deficiencies recur across inspections.

Examples include:

Unclear Responsibilities

Personnel cannot explain who owns specific activities.

Poor Escalation Processes

Important concerns are not communicated appropriately.

Weak Documentation

Governance decisions cannot be reconstructed.

Limited QPPV Visibility

Significant signals do not receive adequate oversight.

Fragmented Decision-Making

Different functions reach conclusions independently without coordinated review.

Poor Integration

Signal management outputs do not influence broader benefit-risk activities.

These weaknesses often reduce confidence in the overall pharmacovigilance system.

Characteristics of Mature Governance Frameworks

Mature signal management governance frameworks generally demonstrate:

• Clearly defined responsibilities
• Formal decision-making processes
• Effective escalation pathways
• Appropriate QPPV visibility
• Strong documentation practices
• Integration with benefit-risk activities
• Consistent implementation across products

Such frameworks support both regulatory compliance and effective safety oversight.

Key Takeaways

Signal management is both a scientific activity and a governance process.

Governance frameworks establish responsibilities, define decision-making authority and ensure that significant safety concerns receive appropriate oversight.

Escalation pathways, committee structures and documentation practices are important components of effective governance.

The QPPV should maintain visibility of significant signal-related activities through established governance processes.

Inspection findings are frequently associated with governance weaknesses rather than shortcomings in statistical methodologies.

References

1. EMA Good Pharmacovigilance Practices (GVP) Module IX – Signal Management.
2. EMA Good Pharmacovigilance Practices (GVP) Module I – Pharmacovigilance Systems and Their Quality Systems.
3. EMA Good Pharmacovigilance Practices (GVP) Module V – Risk Management Systems.
4. Commission Implementing Regulation (EU) No 520/2012.
5. Regulation (EC) No 726/2004.
6. Directive 2001/83/EC.
7. CIOMS VIII Practical Aspects of Signal Detection in Pharmacovigilance.
8. ICH E2E Pharmacovigilance Planning.
9. ICH E2C(R2) Periodic Benefit-Risk Evaluation Report.